348 related articles for article (PubMed ID: 33141839)
21. Increased expression of OPN contributes to idiopathic pulmonary fibrosis and indicates a poor prognosis.
Ji J; Zheng S; Liu Y; Xie T; Zhu X; Nie Y; Shen Y; Han X
J Transl Med; 2023 Sep; 21(1):640. PubMed ID: 37726818
[TBL] [Abstract][Full Text] [Related]
22. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
[TBL] [Abstract][Full Text] [Related]
23. Tree shrews as a new animal model for systemic sclerosis research.
Zheng L; Chen S; Wu Q; Li X; Zeng W; Dong F; An W; Qin F; Lei L; Zhao C
Front Immunol; 2024; 15():1315198. PubMed ID: 38343538
[TBL] [Abstract][Full Text] [Related]
24. Protease activated receptor-1 regulates macrophage-mediated cellular senescence: a risk for idiopathic pulmonary fibrosis.
Lin C; Rezaee F; Waasdorp M; Shi K; van der Poll T; Borensztajn K; Spek CA
Oncotarget; 2015 Nov; 6(34):35304-14. PubMed ID: 26474459
[TBL] [Abstract][Full Text] [Related]
25. Investigating the role of platelets and platelet-derived transforming growth factor-β in idiopathic pulmonary fibrosis.
Chong DLW; Mikolasch TA; Sahota J; Rebeyrol C; Garthwaite HS; Booth HL; Heightman M; Denneny EK; José RJ; Khawaja AA; Duckworth A; Labelle M; Scotton CJ; Porter JC
Am J Physiol Lung Cell Mol Physiol; 2023 Oct; 325(4):L487-L499. PubMed ID: 37643008
[TBL] [Abstract][Full Text] [Related]
26. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
[TBL] [Abstract][Full Text] [Related]
27. Single-nucleus chromatin accessibility identifies a critical role for TWIST1 in idiopathic pulmonary fibrosis myofibroblast activity.
Valenzi E; Bahudhanapati H; Tan J; Tabib T; Sullivan DI; Nouraie M; Sembrat J; Fan L; Chen K; Liu S; Rojas M; Lafargue A; Felsher DW; Tran PT; Kass DJ; Lafyatis R
Eur Respir J; 2023 Jul; 62(1):. PubMed ID: 37142338
[TBL] [Abstract][Full Text] [Related]
28. The purinergic receptor subtype P2Y2 mediates chemotaxis of neutrophils and fibroblasts in fibrotic lung disease.
Müller T; Fay S; Vieira RP; Karmouty-Quintana H; Cicko S; Ayata K; Zissel G; Goldmann T; Lungarella G; Ferrari D; Di Virgilio F; Robaye B; Boeynaems JM; Blackburn MR; Idzko M
Oncotarget; 2017 May; 8(22):35962-35972. PubMed ID: 28415591
[TBL] [Abstract][Full Text] [Related]
29. PGC1α repression in IPF fibroblasts drives a pathologic metabolic, secretory and fibrogenic state.
Caporarello N; Meridew JA; Jones DL; Tan Q; Haak AJ; Choi KM; Manlove LJ; Prakash YS; Tschumperlin DJ; Ligresti G
Thorax; 2019 Aug; 74(8):749-760. PubMed ID: 31182654
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of CXCL6 in secretory cells drives fibroblast collagen synthesis and is associated with increased mortality in idiopathic pulmonary fibrosis.
Bahudhanapati H; Tan J; Apel RM; Seeliger B; Schupp J; Li X; Sullivan DI; Sembrat J; Rojas M; Tabib T; Valenzi E; Lafyatis R; Mitash N; Hernandez Pineda R; Jawale C; Peroumal D; Biswas P; Tedrow J; Adams T; Kaminski N; Wuyts WA; McDyer JF; Gibson KF; Alder JK; Königshoff M; Zhang Y; Nouraie M; Prasse A; Kass DJ
Eur Respir J; 2024 Jan; 63(1):. PubMed ID: 37918852
[TBL] [Abstract][Full Text] [Related]
31. Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis.
O'Dwyer DN; Ashley SL; Gurczynski SJ; Xia M; Wilke C; Falkowski NR; Norman KC; Arnold KB; Huffnagle GB; Salisbury ML; Han MK; Flaherty KR; White ES; Martinez FJ; Erb-Downward JR; Murray S; Moore BB; Dickson RP
Am J Respir Crit Care Med; 2019 May; 199(9):1127-1138. PubMed ID: 30789747
[No Abstract] [Full Text] [Related]
32. Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis.
Ghebremariam YT; Cooke JP; Gerhart W; Griego C; Brower JB; Doyle-Eisele M; Moeller BC; Zhou Q; Ho L; de Andrade J; Raghu G; Peterson L; Rivera A; Rosen GD
J Transl Med; 2015 Aug; 13():249. PubMed ID: 26231702
[TBL] [Abstract][Full Text] [Related]
33. Fibrogenic Lung Injury Induces Non-Cell-Autonomous Fibroblast Invasion.
Ahluwalia N; Grasberger PE; Mugo BM; Feghali-Bostwick C; Pardo A; Selman M; Lagares D; Tager AM
Am J Respir Cell Mol Biol; 2016 Jun; 54(6):831-42. PubMed ID: 26600305
[TBL] [Abstract][Full Text] [Related]
34. TREM2 Insufficiency Protects against Pulmonary Fibrosis by Inhibiting M2 Macrophage Polarization.
Luo Q; Deng D; Li Y; Shi H; Zhao J; Qian Q; Wang W; Cai J; Yu W; Liu J
Int Immunopharmacol; 2023 May; 118():110070. PubMed ID: 37003186
[TBL] [Abstract][Full Text] [Related]
35. An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model.
Jarman ER; Khambata VS; Cope C; Jones P; Roger J; Ye LY; Duggan N; Head D; Pearce A; Press NJ; Bellenie B; Sohal B; Jarai G
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):158-69. PubMed ID: 23977848
[TBL] [Abstract][Full Text] [Related]
36. Macrophage expressed tartrate-resistant acid phosphatase 5 promotes pulmonary fibrosis progression.
Bergwik J; Bhongir RKV; Padra M; Adler A; Olm F; Lång P; Lindstedt S; Andersson G; Egesten A; Tanner L
Immunology; 2024 Apr; 171(4):583-594. PubMed ID: 38178705
[TBL] [Abstract][Full Text] [Related]
37. Exosome-Derived microRNA-22 Ameliorates Pulmonary Fibrosis by Regulating Fibroblast-to-Myofibroblast Differentiation in Vitro and in Vivo.
Kuse N; Kamio K; Azuma A; Matsuda K; Inomata M; Usuki J; Morinaga A; Tanaka T; Kashiwada T; Atsumi K; Hayashi H; Saito Y; Seike M; Gemma A
J Nippon Med Sch; 2020 Jul; 87(3):118-128. PubMed ID: 31776321
[TBL] [Abstract][Full Text] [Related]
38. The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis.
Williamson JD; Sadofsky LR; Hart SP
Exp Lung Res; 2015 Mar; 41(2):57-73. PubMed ID: 25514507
[TBL] [Abstract][Full Text] [Related]
39. Myeloid-specific deletion of activating transcription factor 6 alpha increases CD11b
Mekhael O; Revill SD; Hayat AI; Cass SP; MacDonald K; Vierhout M; Ayoub A; Reihani A; Padwal M; Imani J; Ayaub E; Yousof T; Dvorkin-Gheva A; Rullo A; Hirota JA; Richards CD; Bridgewater D; Stämpfli MR; Hambly N; Naqvi A; Kolb MR; Ask K
Immunol Cell Biol; 2023 May; 101(5):412-427. PubMed ID: 36862017
[TBL] [Abstract][Full Text] [Related]
40. Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.
Tang X; Peng R; Phillips JE; Deguzman J; Ren Y; Apparsundaram S; Luo Q; Bauer CM; Fuentes ME; DeMartino JA; Tyagi G; Garrido R; Hogaboam CM; Denton CP; Holmes AM; Kitson C; Stevenson CS; Budd DC
Am J Pathol; 2013 Aug; 183(2):470-9. PubMed ID: 23759512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
